🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.500
-0.140 (-5.30%)
At close: Nov 19, 2026, 4:00 PM EST
2.510
+0.010 (0.40%)
After-hours: Nov 19, 2026, 4:10 PM EST

Intensity Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-12.04-11.61-16.27-10.54-7.58-7.9
Other Amortization
---0.16--
Asset Writedown & Restructuring Costs
0.030.030.030.150.180.17
Stock-Based Compensation
1.7423.121.41.170.72
Other Operating Activities
---2.26--
Change in Accounts Payable
0.50.36-2.271.630.7-0.05
Change in Other Net Operating Assets
0.7-0.010.17-2.260.050.23
Operating Cash Flow
-9.07-9.23-15.22-7.21-5.48-6.83
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Investment in Securities
--6.35-6.02--
Investing Cash Flow
--6.35-6.02--

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---0.232.252
Total Debt Issued
---0.232.252
Net Debt Issued (Repaid)
---0.232.252
Issuance of Common Stock
11.1820.383.5522.48-0.05
Other Financing Activities
-0.68-1.82-0.65-2.23--
Financing Cash Flow
10.4918.562.920.472.252.05

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
1.439.33-5.977.24-3.23-4.78

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-5.58-5.11-9.54-2.77-2.74-3.97
Unlevered Free Cash Flow
-5.58-5.11-9.54-2.74-2.69-3.97

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
1.20.35-2.1-0.630.760.18
SEC Filings: 10-K · 10-Q